RECORD // Company

Apnimed, Inc.

Built 2026-11-22T00:36:21Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (1 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

SEC EDGAR (1)
Matched by name only, not merged (5)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • APNIMED, INC · Ct business · same registered legal name as 'Apnimed, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • Apnimed · Ctgov · exact name match to 'Apnimed, Inc.' (no other entity shares the name) Possible match based on name, not a shared identifier. Compare the records. Compare
  • Apnimed Inc. · Ctgov · same registered legal name as 'Apnimed, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • APNIMED INC · East licences · same registered legal name as 'Apnimed, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • APNIMED, INC. · Ny corps · same registered legal name as 'Apnimed, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare

3 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-16 · accession 0001193125-26-462185

ItemValuePeriodFormFiledAccessionReport
Revenue$2,480,0003 months ended 2026-09-3010-Q2026-11-160001193125-26-4621852026-11-22 00:36 UTCReport an error
Net income (loss)$-29,524,0003 months ended 2026-09-3010-Q2026-11-160001193125-26-4621852026-11-22 00:36 UTCReport an error
Cash and cash equivalents$351,826,000at 2026-09-3010-Q2026-11-160001193125-26-4621852026-11-22 00:36 UTCReport an error

Negative as reported in the filing.

Not in this report's XBRL: Interest expense.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001745648
Ticker
APMD
EIN
821910611
CUSIP
03770Y107
Record ID
sx:sec:0001745648

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

14 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-16SEC EDGAR company profile2026-11-22 00:36 UTCReport an error
SIC industry2834 Pharmaceutical Preparations2026-11-16SEC EDGAR company profile2026-11-22 00:36 UTCReport an error
State of incorporationDE2026-11-16SEC EDGAR company profile2026-11-22 00:36 UTCReport an error
Fiscal year end (MMDD)12312026-11-16SEC EDGAR company profile2026-11-22 00:36 UTCReport an error
Business address39 JOHN F. KENNEDY STREET, 4TH FLR., CAMBRIDGE, MA, 021382026-11-16SEC EDGAR company profile2026-11-22 00:36 UTCReport an error
ExchangesNasdaq2026-11-16SEC EDGAR company profile2026-11-22 00:36 UTCReport an error
Form D total offering amount (D filed 2026-03-27)$24,999,9942026-03-27D2026-11-22 00:36 UTCReport an error
Form D total amount sold (D filed 2026-03-27)$24,999,9942026-03-27D2026-11-22 00:36 UTCReport an error
Form D industry groupPharmaceuticals2026-03-27D2026-11-22 00:36 UTCReport an error
Form D revenue rangeDecline to Disclose2026-03-27D2026-11-22 00:36 UTCReport an error
Form D date of first sale2026-03-112026-03-27D2026-11-22 00:36 UTCReport an error
8-K Item 2.02 (filed 2026-11-16)Results of Operations and Financial Condition On November 16, 2026, Apnimed, Inc. issued a press release announcing its financial results for the quarterly period ended September 30, 2026. The full text of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 2.02 of this Form 8-K and the Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be…2026-11-16SEC EDGAR 8-K 0001193125-26-462171 (text as filed, excerpt)2026-11-22 00:36 UTCReport an error
8-K Item 4.02 (filed 2026-11-13)Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review On November 13, 2026, the Audit Committee of the Board of Directors (the “Audit Committee”) of Apnimed, Inc. (the “Company”), based on the recommendation of the Company’s management, concluded that the Company’s previously issued financial statements, as described below, should no longer be relied upon due to an error identified in the classification of the gain on the disposition of the Company’s equity method investment in Shionogi-Apnimed Sleep Science, LLC (“SASS”) for the three and six months ended June 30, 2026 as a gain in continuing operations rather than discontinued…2026-11-13SEC EDGAR 8-K 0001193125-26-460864 (text as filed, excerpt)2026-11-22 00:36 UTCReport an error
8-K Item 2.02 (filed 2026-09-08)Results of Operations and Financial Condition On September 8, 2026, Apnimed, Inc. issued a press release announcing its financial results for the quarterly period ended June 30, 2026. The full text of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 2.02 of this Form 8-K and the Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be…2026-09-08SEC EDGAR 8-K 0001193125-26-385355 (text as filed, excerpt)2026-11-22 00:36 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.